-
公开(公告)号:US20050203108A1
公开(公告)日:2005-09-15
申请号:US10980199
申请日:2004-11-03
申请人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Christensen , Behrend Lundt , Ulla Sidelmann , Henning Thogersen , Anthony Ling , Michael Plewe , Larry Truesdale , Anker Jogensen , Janos Kodra , Shenghua Shi
发明人: Jesper Lau , Peter Madsen , Christian Sams , Carsten Behrens , Josef Vagner , Inge Christensen , Behrend Lundt , Ulla Sidelmann , Henning Thogersen , Anthony Ling , Michael Plewe , Larry Truesdale , Anker Jogensen , Janos Kodra , Shenghua Shi
IPC分类号: C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07D209/08 , C07D209/48 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04 , A61K31/519 , A61K31/415 , A61K31/445
CPC分类号: C07D209/48 , C07B2200/07 , C07C237/36 , C07C237/42 , C07C243/38 , C07C271/56 , C07C271/58 , C07C275/24 , C07C275/26 , C07C275/28 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/38 , C07C275/42 , C07C275/60 , C07C275/62 , C07C311/47 , C07C317/22 , C07C317/32 , C07C317/42 , C07C323/21 , C07C323/44 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C2603/18 , C07C2603/68 , C07C2603/94 , C07D209/08 , C07D211/58 , C07D213/75 , C07D215/38 , C07D231/40 , C07D235/30 , C07D257/06 , C07D277/72 , C07D295/13 , C07D295/135 , C07D307/68 , C07D317/66 , C07D319/18 , C07D319/20 , C07D333/20 , C07D333/38 , C07D333/60 , C07D333/68 , C07D333/70 , C07D409/12 , C07D417/12 , C07D487/04
摘要: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any glucagon-mediated conditions and diseases such as hyperglycemia, Type 1 diabetes, Type 2 diabetes and obesity.
摘要翻译: 一类新颖的化合物,其作用是拮抗胰高血糖素激素对胰高血糖素受体的作用。 由于它们对胰高血糖素受体的拮抗作用,所述化合物可适用于治疗和/或预防任何胰高血糖素介导的病症和疾病如高血糖症,1型糖尿病,2型糖尿病和肥胖症。
-
公开(公告)号:US20070015757A1
公开(公告)日:2007-01-18
申请号:US11424871
申请日:2006-06-18
申请人: Peter Madsen , Jesper Lau , Janos Kodra , Inge Christensen
发明人: Peter Madsen , Jesper Lau , Janos Kodra , Inge Christensen
IPC分类号: A61K31/53 , A61K31/50 , A61K31/505 , A61K31/4965 , A61K31/455 , A61K31/433 , A61K31/426 , A61K31/425 , A61K31/421 , A61K31/42 , A61K31/4196 , A61K31/4192 , A61K31/415 , A61K31/381 , A61K31/35 , A61K31/34 , A61K31/198
CPC分类号: C07D207/323 , C07C235/84 , C07D233/96 , C07D237/08 , C07D261/18
摘要: Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
摘要翻译: 用于拮抗胰高血糖素肽激素对胰高血糖素受体的作用的新型化合物。 更具体地,涉及胰高血糖素拮抗剂或反向激动剂。
-
公开(公告)号:US20050256175A1
公开(公告)日:2005-11-17
申请号:US11063117
申请日:2005-02-22
申请人: Jesper Lau , Inger Christensen , Peter Madsen , Paw Bloch , Carsten Behrens , Janos Kodra , Poul Nielsen
发明人: Jesper Lau , Inger Christensen , Peter Madsen , Paw Bloch , Carsten Behrens , Janos Kodra , Poul Nielsen
IPC分类号: A61K31/195 , A61K31/198 , A61K31/41 , A61K31/4439 , A61K45/06 , A61K31/428 , A61K31/426
CPC分类号: A61K45/06 , A61K31/195 , A61K31/198 , A61K31/41 , A61K31/4439 , A61K2300/00
摘要: Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
摘要翻译: 用于拮抗胰高血糖素肽激素对胰高血糖素受体的作用的新型化合物。 更具体地,涉及胰高血糖素拮抗剂或反向激动剂。
-
4.N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes 失效
标题翻译: N-杂芳基吲哚羧酰胺及其类似物,用于糖尿病治疗中的glcokinase激活剂公开(公告)号:US20070027140A1
公开(公告)日:2007-02-01
申请号:US11439820
申请日:2006-05-24
申请人: Jesper Lau , Per Vedso , Janos Kodra , Anthony Murray , Lone Jeppesen , Michael Ankersen , Govindan Subramanian , Adnan Mjalli , Robert Andrews , Dharma Pollisetti , Daniel Christen
发明人: Jesper Lau , Per Vedso , Janos Kodra , Anthony Murray , Lone Jeppesen , Michael Ankersen , Govindan Subramanian , Adnan Mjalli , Robert Andrews , Dharma Pollisetti , Daniel Christen
IPC分类号: A61K31/551 , A61K31/5377 , A61K31/513 , A61K31/497 , A61K31/496 , A61K31/4745 , A61K31/427 , A61K31/422 , A61K31/433 , A61K31/4245 , A61K31/416 , A61K31/405
CPC分类号: C07D401/12 , C07D403/12 , C07D417/12 , C07D491/04
摘要: This invention relates to compounds that are activators of glucokinase and thus may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial. The compounds are of the general formula (I) wherin A and B are further defined in the application.
摘要翻译: 本发明涉及作为葡萄糖激酶活化剂的化合物,因此可用于治疗,治疗,控制或辅助治疗疾病,其中增加葡糖激酶活性是有益的。 所述化合物具有通式(I),在本申请中进一步定义了A和B。
-
公开(公告)号:US20080119454A1
公开(公告)日:2008-05-22
申请号:US11981997
申请日:2007-10-31
申请人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Valcarce-Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
发明人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Valcarce-Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
IPC分类号: A61K31/55 , A61K31/427 , A61K31/454 , C07D417/02
CPC分类号: C07D277/38 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/55 , A61K45/06 , C07D213/75 , C07D277/46 , C07D277/48 , C07D277/52 , C07D277/54 , C07D277/56 , C07D285/135 , C07D417/06 , C07D417/12 , C07D417/14 , C07D473/38
摘要: This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
-
公开(公告)号:US20080119455A1
公开(公告)日:2008-05-22
申请号:US11982248
申请日:2007-10-31
申请人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Valcarce-Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
发明人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Valcarce-Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
IPC分类号: A61K31/55 , A61K31/454 , A61K31/427 , C07D417/02
CPC分类号: C07D277/38 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/55 , A61K45/06 , C07D213/75 , C07D277/46 , C07D277/48 , C07D277/52 , C07D277/54 , C07D277/56 , C07D285/135 , C07D417/06 , C07D417/12 , C07D417/14 , C07D473/38
摘要: This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
-
公开(公告)号:US20060183783A1
公开(公告)日:2006-08-17
申请号:US11365534
申请日:2006-03-01
申请人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
发明人: Dharma Polisetti , Janos Kodra , Jesper Lau , Paw Bloch , Maria Lopez , Niels Blume , Mustafa Guzel , Kalpathy Santhosh , Adnan Mjalli , Robert Andrews , Govindan Subramanian , Michael Ankersen , Per Vedso , Anthony Murray , Lone Jeppesen
IPC分类号: A61K31/426 , C07D277/18
CPC分类号: C07D213/75 , C07D277/48 , C07D277/52 , C07D277/54 , C07D277/56 , C07D285/135 , C07D417/06 , C07D417/12 , C07D417/14 , C07D473/38
摘要: This invention relates to aryl carbonyl derivativeswhich are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
摘要翻译: 本发明涉及芳基羰基衍生物,其是可用于治疗,治疗,控制或辅助治疗疾病的葡糖激酶的活化剂,其中增加葡糖激酶活性是有益的。
-
8.Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides 审中-公开
标题翻译: 新结构明确的支化聚合物作为肽缀合剂的合成和应用公开(公告)号:US20060182714A1
公开(公告)日:2006-08-17
申请号:US11344767
申请日:2006-02-01
申请人: Carsten Behrens , Florencio Dorwald , Mikael Kofod-Hansen , Jesper Lau , Janos Kodra , Thomas Hansen , Paw Bloch
发明人: Carsten Behrens , Florencio Dorwald , Mikael Kofod-Hansen , Jesper Lau , Janos Kodra , Thomas Hansen , Paw Bloch
CPC分类号: C12P21/005 , A61K47/549 , A61K47/60 , C12N9/6437
摘要: The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein.
摘要翻译: 本发明提供新的结构明确的支化聚合物作为肽和蛋白质的助剂的合成和应用。
-
公开(公告)号:US20080076705A1
公开(公告)日:2008-03-27
申请号:US11814019
申请日:2006-02-01
申请人: Janos Kodra , Patrick Garibay , Thomas Hoeg-Jensen , Ib Jonassen , Peter Madsen , Tina Tagmose
发明人: Janos Kodra , Patrick Garibay , Thomas Hoeg-Jensen , Ib Jonassen , Peter Madsen , Tina Tagmose
摘要: The present invention relates to insulin derivatives having a side chain attached either to the -amino group of the N-terminal amino acid residue of the B chain or to the amino group of a Lys residue present in the B chain of the parent insulin via an amide bond which side chain comprises at least one aromatic group; at least one free carboxylic acid group or a group which is negatively charged at neutral pH, a fatty acid moiety with 4 to 22 carbon atoms in the carbon chain; and possible linkers which link the individual components in the side chain together via amide bonds.
摘要翻译: 本发明涉及具有侧链连接到B链的N末端氨基酸残基的氨基或者存在于母体胰岛素的B链中的Lys残基的氨基的胰岛素衍生物,其通过 酰胺键,该侧链包含至少一个芳族基团; 至少一个游离羧酸基团或在中性pH下带负电荷的基团,碳链中具有4-22个碳原子的脂肪酸部分; 以及通过酰胺键将侧链中各个组分连接在一起的可能接头。
-
公开(公告)号:US20060105948A1
公开(公告)日:2006-05-18
申请号:US11235737
申请日:2005-09-22
申请人: Janos Kodra , Nils Johansen , Lars Thim , Bernd Peschke
发明人: Janos Kodra , Nils Johansen , Lars Thim , Bernd Peschke
IPC分类号: C07K14/605 , A61K38/26
CPC分类号: C07K14/605 , A61K38/00 , A61K47/60
摘要: The present invention relates to novel derivatives of human glucagon-like peptide-2 (GLP-2) peptides, which have a protracted profile of action, as well as pharmaceutical compositions, uses and methods of treatment.
摘要翻译: 本发明涉及具有延长的作用曲线的人胰高血糖素样肽-2(GLP-2)肽的新型衍生物,以及药物组合物,用途和治疗方法。
-
-
-
-
-
-
-
-
-